Longitude Capital specializes in making venture growth investments in biotechnology, medical technology, and health solutions companies. The firm seeks to improve clinical outcomes, enhance patient quality of life, and reduce the cost of care. Since 2006, Longitude Capital has raised over $2 billion across six funds, investing through various methods. The firm focuses on both clinical-stage and commercial-stage assets.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions